Sabbagh Marwan 4

What Happened

• Marwan Sabbagh, a director of CervoMed Inc. (CRVO), was granted an award on 2026-06-08 giving him an option to purchase 8,150 shares of common stock. The grant is reported as a derivative award (transaction code A) at $0.00 per share (no cash paid on grant).

Key Details

• Transaction date: 2026-06-08; Form 4 filed: 2026-06-10 (appears timely, within the 2‑business‑day Form 4 window).
• Award: option to purchase 8,150 shares under the 2025 Equity Incentive Plan (reported as 8,150 shares acquired at $0.00).
• Vesting: monthly over one year in equal 1/12th installments, beginning June 30, 2026, subject to continued service.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: grant was made in connection with Sabbagh’s election to the board and follows the company’s non-employee director compensation policy.

Context

• This is a common form of director compensation (an equity award/option), not an immediate purchase of shares. The option vests over time, so the director must remain in service to realize the underlying shares. Such awards are typically routine and do not, by themselves, signal immediate buying or selling pressure.